These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1670768)

  • 21. Regulation of an IMP dehydrogenase gene and its overexpression in drug-sensitive transcription elongation mutants of yeast.
    Shaw RJ; Wilson JL; Smith KT; Reines D
    J Biol Chem; 2001 Aug; 276(35):32905-16. PubMed ID: 11441018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial purification, properties and regulation of inosine 5'phosphate dehydrogenase in normal and malignant rat tissues.
    Jackson RC; Morris HP; Weber G
    Biochem J; 1977 Jul; 166(1):1-10. PubMed ID: 197916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IMP dehydrogenase from Pneumocystis carinii as a potential drug target.
    O'Gara MJ; Lee CH; Weinberg GA; Nott JM; Queener SF
    Antimicrob Agents Chemother; 1997 Jan; 41(1):40-8. PubMed ID: 8980752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active-site modification of native and mutant forms of inosine 5'-monophosphate dehydrogenase from Escherichia coli K12.
    Gilbert HJ; Drabble WT
    Biochem J; 1980 Nov; 191(2):533-41. PubMed ID: 6112982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
    Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
    Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
    Wright DG; Boosalis M; Malek K; Waraska K
    Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the IMP binding site in the IMP dehydrogenase from Tritrichomonas foetus.
    Huete-Pérez JA; Wu JC; Whitby FG; Wang CC
    Biochemistry; 1995 Oct; 34(42):13889-94. PubMed ID: 7577983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification, characterization, and kinetic analysis of inosine 5'-monophosphate dehydrogenase of Tritrichomonas foetus.
    Verham R; Meek TD; Hedstrom L; Wang CC
    Mol Biochem Parasitol; 1987 May; 24(1):1-12. PubMed ID: 2886911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
    Balzarini J; De Clercq E
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):785-90. PubMed ID: 1359876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide.
    Griesmacher A; Weigel G; Seebacher G; Müller MM
    Clin Chem; 1997 Dec; 43(12):2312-7. PubMed ID: 9439448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human type I and II IMP dehydrogenases as drug targets.
    Natsumeda Y; Carr SF
    Ann N Y Acad Sci; 1993 Nov; 696():88-93. PubMed ID: 7906497
    [No Abstract]   [Full Text] [Related]  

  • 32. Cloning and sequence analysis of the human and Chinese hamster inosine-5'-monophosphate dehydrogenase cDNAs.
    Collart FR; Huberman E
    J Biol Chem; 1988 Oct; 263(30):15769-72. PubMed ID: 2902093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning and sequence of the human type II IMP dehydrogenase gene.
    Glesne DA; Huberman E
    Biochem Biophys Res Commun; 1994 Nov; 205(1):537-44. PubMed ID: 7999076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression, purification, and characterization of inosine 5'-monophosphate dehydrogenase from Borrelia burgdorferi.
    Zhou X; Cahoon M; Rosa P; Hedstrom L
    J Biol Chem; 1997 Aug; 272(35):21977-81. PubMed ID: 9268334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
    Szekeres T; Fritzer M; Pillwein K; Felzmann T; Chiba P
    Life Sci; 1992; 51(16):1309-15. PubMed ID: 1357518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning of a rat cDNA encoding retinal dehydrogenase isozyme type I and its expression in E. coli.
    Penzes P; Wang X; Sperkova Z; Napoli JL
    Gene; 1997 Jun; 191(2):167-72. PubMed ID: 9218716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning, sequencing, and structural analysis of the DNA encoding inosine monophosphate dehydrogenase (EC 1.1.1.205) from Tritrichomonas foetus.
    Beck JT; Zhao S; Wang CC
    Exp Parasitol; 1994 Feb; 78(1):101-12. PubMed ID: 7905423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the tac promoter and lacIq for the controlled expression of Zymomonas mobilis fermentative genes in Escherichia coli and Zymomonas mobilis.
    Arfman N; Worrell V; Ingram LO
    J Bacteriol; 1992 Nov; 174(22):7370-8. PubMed ID: 1429459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of inosine monophosphate dehydrogenase expression during retinal development: differences between variants and isoforms.
    Gunter JH; Thomas EC; Lengefeld N; Kruger SJ; Worton L; Gardiner EM; Jones A; Barnett NL; Whitehead JP
    Int J Biochem Cell Biol; 2008; 40(9):1716-28. PubMed ID: 18295529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enzymes of the inosinic crossing point in human lymphocytes].
    Tabucchi A; Vannoni D; Porcelli B; Di Stefano A; Pizzichini M; Leoncini R; Dispensa E; Marinello E
    Boll Soc Ital Biol Sper; 1990 May; 66(5):449-55. PubMed ID: 1975748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.